CliffBio
small molecule

TESTOSTERONE ENANTHATE

TESTOSTERONE ENANTHATE

Loss of exclusivity—loss of exclusivity
CompanyNexus Labs →See this company's full patent-cliff portfolio

Drug detail

Brand nameTESTOSTERONE ENANTHATE
Active ingredientTESTOSTERONE ENANTHATE
Strength200MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJune 2006
Marketing statusRX

More from Nexus Labs

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

TESTOSTERONE ENANTHATE patent cliff — loss of exclusivity — | CliffBio